Tibor Kovacsovics

Tibor Kovacsovics

UNVERIFIED PROFILE

Are you Tibor Kovacsovics?   Register this Author

Register author
Tibor Kovacsovics

Tibor Kovacsovics

Publications by authors named "Tibor Kovacsovics"

Are you Tibor Kovacsovics?   Register this Author

38Publications

1118Reads

24Profile Views

Cost-effectiveness of technetium pyrophosphate scintigraphy heart biopsy for the diagnosis of transthyretin amyloidosis.

Amyloid 2019;26(sup1):71-72

a Department of Pharmacotherapy, University of Utah College of Pharmacy , Salt Lake City , UT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13506129.2019.1583192DOI Listing
January 2019

CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation.

Leuk Res 2017 02 12;53:39-49. Epub 2016 Dec 12.

Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.12.002DOI Listing
February 2017

MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk.

Neurology 2017 02 6;88(6):603-604. Epub 2017 Jan 6.

From the University of Utah (K.J.-S., A.G.S., T.K., D.S., M.G., E.P.Q.); Huntsman Cancer Institute (C.A.P.), Salt Lake City, UT; and University of Vermont Medical Center (N.K.), Burlington.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000003590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304461PMC
February 2017

Functional integration of acute myeloid leukemia into the vascular niche.

Leukemia 2014 Oct 18;28(10):1978-1987. Epub 2014 Mar 18.

Oregon Stem Cell Center, Papé Family Pediatric Research Institute, Department of Pediatrics, Oregon Health & Sciences University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2014.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167983PMC
October 2014

Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.

Clin Lymphoma Myeloma Leuk 2014 Oct 16;14(5):424-430.e1. Epub 2014 Feb 16.

Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.02.003DOI Listing
October 2014

RNAi screen for rapid therapeutic target identification in leukemia patients.

Proc Natl Acad Sci U S A 2009 May 11;106(21):8695-700. Epub 2009 May 11.

Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0903233106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680429PMC
May 2009

Peritoneal tuberculosis after imatinib therapy.

Arch Intern Med 2009 Feb;169(3):312-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinternmed.2008.581DOI Listing
February 2009

Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics.

Eur J Nucl Med Mol Imaging 2005 Aug 12;32(8):943-51. Epub 2005 Apr 12.

Service of Nuclear Medicine, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-005-1798-8DOI Listing
August 2005

Developing a European network for adult ALL.

Hematol J 2004 ;5 Suppl 3:S46-52

Medical Department III, Hematology, Oncology, Rheumatology and Infectiology, J.W. Goethe University Hospital, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200422DOI Listing
November 2004